The study of single-cell omics provides unique information regarding the heterogeneity of cellular populations at various levels of the central dogma of molecular biology. This knowledge facilitates a deeper understanding of how underlying molecular and architectural changes alter cell behavior, development, and disease processes. The emerging microchip-based tools for single-cell omics analysis are enabling the evaluation of cellular omics with high throughput, improved sensitivity, and reduced cost. We review state-ofthe-art microchip platforms for profiling genomics, epigenomics, transcriptomics, proteomics, metabolomics, and multi-omics at single-cell resolution. We also discuss the background of and challenges in the analysis of each molecular layer and integration of multiple levels of omics data, as well as how microchip-based methodologies benefit these fields. Additionally, we examine the advantages and limitations of these approaches. Looking forward, we describe additional challenges and future opportunities that will facilitate the improvement and broad adoption of single-cell omics in life science and medicine.
INTRODUCTION
For decades, the cell has been studied primarily as a part of its bulk population. However, the study of these seemingly isogenic cellular populations often buries diverse cellular characteristics. Even in cells with the same cellular history, heterogeneity inherently arises owing to the stochastic fluctuation of gene expression during transcription and translation or noise in signaling pathways (1, 2) . These hidden cell-to-cell variations can be paramount in the diagnosis and treatment of disease (3) . For instance, the heterogeneity of tumor cells is crucial in understanding tumor initiation, progression, metastasis, and therapeutic response (4) . A very small subpopulation of cells that may confer the most resistance in a preclinical drug test could be responsible for tumor relapse in patients after treatment (5, 6) . Thus, as medicine becomes more and more personalized, there is a greater desire to more accurately represent and understand single cells and these distinct subpopulations. The newfound awareness of cellular heterogeneity has spurred a single-cell movement in the field of omics studies, investigating the genome, epigenome, transcriptome, proteome, and metabolome and their inherent interactions.
Traditionally, microscopy, flow cytometry, and mass cytometry have been widely implemented in single-cell analysis. Light microscopy technologies measure cellular morphology with high spatiotemporal resolution, which pioneered our understanding of basic cellular characteristics (7) . Imaging fluorescent signals further enabled the detection of specific biomolecules in single cells. However, this method often suffers from low throughput and requires bulky and expensive setup. Technical challenges make it impractical for global profiling of cellular states and discovery of novel cellular features and subsets (8, 9) . Alternatively, flow cytometry is used to study single cells in a high-throughput manner (>1,000 cells per second). It uses fluorescent probes conjugated to antibodies to identify multiple parameters at the single-cell level, and targeted cells can be sorted downstream via fluorescence-activated cell sorting (FACS) (10) (11) (12) . However, the cells are exposed to physical stressors, including fluidic pressure, laser beams, electrostatic charges, high voltage fields, and collisions with container surfaces, thereby influencing cellular recovery and integrity (13) . Although these methodologies allow for the identification of cellular phenotypes, the antibody panels are chosen on the basis of a priori knowledge, limiting the opportunity for new discoveries. In addition, these methods require approximately 1,000,000 cells and do not allow for the measurement of metabolites or dynamic monitoring of cells over time (14) . The emission spectra overlap of the fluorophores leads to a greater amount of background signal and makes it difficult to distinguish between the already limited number of parameters. To overcome the issue, mass cytometry, which combines flow cytometry and mass spectroscopy, is
GENOME
Genetic mutations and variations can be inherited or arise during cell proliferation and differentiation, ultimately resulting in genotypic heterogeneity (26) (27) (28) (29) . Through whole-genome sequencing, the mutations, structural variations, aneuploidies, and recombination in the genome can be characterized (30) (31) (32) (33) (34) (35) (36) . It has also been used to study cell-lineage relationships as well as the diversity, evolution, and role of genetic mosaicism (37) (38) (39) (40) . However, owing to the small quantity of starting material in single cells, the genomic DNA (gDNA) from single cells must be amplified through whole-genome amplification (WGA) prior to sequencing.
Either polymerase chain reaction (PCR)-based methodologies or isothermal multiple displacement amplification (MDA) can amplify whole genomes of single cells (41) . Both techniques result in a vast number of amplification biases. Reported issues include varying amounts of nonuniform coverage of the genome, generation of chimeric DNA, base copy errors, false-positive errors, false-negative errors, and locus and allelic dropouts (ADOs) (42, 43) . Degenerate-oligonucleotideprimed PCR enabled genome-wide amplification of DNA in single cells, and a multiple annealing and loop-based amplification cycling followed by PCR further improved performance (44, 45) . Although PCR-based methods have more uniformity compared with MDA, they lack the extensive genome coverage, long DNA product lengths, and sensitive detection of single-nucleotide mutations (44, 46) . Alternatively, isothermal MDA uses random sequence primers and the high-fidelity strand-displacement properties of the Phi29 polymerase to amplify DNA (46, 47) . In addition to challenges with uniformity and amplification bias, MDA also experiences nonspecific synthesis from negative primer interactions, such as primer dimers, or DNA contamination that outcompetes the desired template (48) (49) (50) . With all of these complications, high uniformity and fidelity in WGA are still highly sought after and necessary to precisely identify insertions/deletions, copy number variations (CNVs), single-nucleotide variants (SNVs), structural variants, and other genomic mutations (41) .
To improve amplification uniformity and reduce bias and nonspecific products during WGA, microfluidic systems have been devised that constrict the reaction volume from microliters down to nanoliters or picoliters through compartmentalization, minimizing the contamination from exogenous DNA and cross-compartment mixing (51) . Because each compartment contains a small number of DNA fragments, the competition among DNA templates for primers and polymerases is reduced (52) . This also improves reaction kinetics and efficiency during amplification, thereby greatly reducing amplification bias (41) . In addition, high-throughput analysis of a large number of single cells can be achieved owing to the high parallelization capability of microchip designs (53) .
Typical modalities in microchip-based methods are valves, nanowells, and droplets. By restricting the reaction volume to nanoliters, a valve-based microfluidic device was used to capture and amplify gDNA from single Escherichia coli cells, processing up to nine samples in parallel (Figure 2a) . This tactic reduced cost by minimizing reagent consumption and allowed for improved amplification specificity (up to 95%). Owing to the confinement of the reaction, fewer negative primer interactions, less nonspecific synthesis of DNA templates, and less amplification bias were reported (48) . Taking this concept one step further, a valve-based, fully automated microfluidic device was designed that captures, lyses, and amplifies 96 single cells in parallel (41) . The device uses integrated fluidic circuits to produce nanoliter-scale reactions (54) . Owing to the high throughput, approximately 150-250 ng of DNA per cell were produced, allowing for multiple assays to be run on the same single cell, including targeted resequencing, whole-exome sequencing (WES), and WGS. This device showed improved uniformity with lower ADO rates and fewer single-nucleotide errors (41) . Further capitalizing on the integrated fluidic system, mutation segregation patterns have been identified and clonal structures have been reconstructed following WGA of nearly 1,500 childhood acute lymphoblastic leukemia cells (55) . Microwell platforms also aid in reducing the reaction volume and improve uniformity in WGA (Figure 2b) (56) . This approach allows for highly parallel DNA amplification of single cells in thousands of confined nanoliter reactor chambers. This method has achieved highly uniform coverage in the genomes of both microbial and mammalian cells and demonstrated substantial improvement both in de novo genome assembly from single microbial cells and in the ability to detect small somatic CNVs in individual human adult neurons with minimal sequencing effort. Genome coverage of 88-94% of the entire E. coli genome has been reported using microwell platforms (56) .
Although valves and microwells are commonly used for multistep single-cell reactions, issues with microfabrication and fluid control in parallel microchambers limit the maximum sample processing capability (57) . These constraints have been overcome through the implementation of droplet microfluidics. These methods distributed single-cell gDNA fragments into a large number of picoliter droplets, reducing the reagent competition among DNA fragments during amplification and thereby reducing amplification bias while retaining high accuracy (Figure 2c) (51, (58) (59) (60) . For example, genome coverage ranging from 59% to 89%, SNVs with error rates below 2 × 10 −5 , and decreased unexpected amplification have been reported when using droplet-based methods (51, 58) . However, these platforms isolated and selected single cells either manually or by FACS prior to downstream WGA. To further increase the throughput, single-droplet MDA (sd-MDA) was developed, which adds MDA reagents to already-encapsulated single cells through one-to-one droplet fusion in microfluidic channels (57) . This technique is able to process tens of thousands of single cells per hour and ensures a more uniform and efficient distribution of reagents in each reaction chamber, reducing both sample and reagent loss. By using sd-MDA, amplified genomes were acquired with high coverage and low contamination in both bacterial and mammalian cells (57) .
Despite the use of traditional microfluidic methods such as valves, nanowells, and droplets, new designs have emerged to improve WGA performance. A valveless microfluidic device that allows for single-cell genomic amplification via micropillar arrays (GAMA) has been developed (47, 61) . After the single cells were trapped and lysed on the chip, the micropillars captured gDNA as the other artifacts and cellular components, including the mitochondrial DNA, were washed away. The purified gDNA was then amplified via MDA while under a constant microfluidic flow throughout the amplification process, which allowed for amplified products to be washed downstream into output reservoirs for off-chip analysis. For validation, the genome coverage was compared between the GAMA-and FACS-based methods using gene loci sampling and WES. This revealed improved genome coverage and reduced amplification bias compared with single cells that were amplified in wells following FACS (47) . Marie et al. (46) developed another valveless microfluidic device that is manufactured by injection molding (Figure 2d) . This device has enabled single-cell isolation and genome extraction in subnanoliter volumes using hydrodynamic cell traps. Subsequent MDA-based WGA was then executed by adding microliter volumes to the outlet of the device. Using this workflow, genome coverages of nearly 90% were obtained, and 99% of the DNA sequences mapped to the human genome, revealing no contamination from nonhuman origins. By conducting the WGA in higher volumes and cell lysis in low volumes, the cost and complexity of the device are reduced without sacrificing amplification performance (46) .
To overcome the traditionally complicated microfluidic setup and microfabrication process in microchip platforms, bulk polyethylene glycol hydrogels were used as a virtual microfluidic platform for massively parallel MDA (62) . By forming a gel matrix with a mesh size of 25 nm, cells and DNA templates are compartmentalized owing to the limited diffusion within the gel. This results in localized amplification products as well as minimizing external contaminants and 
EPIGENOME
Epigenetic studies investigate functional genomic elements and their regulatory variations that generate gene expression differences within isogenic cells (63, 64) . Epigenetic modifications, including DNA methylation, histone modifications, chromatin accessibility, and chromosome conformation, are crucial in the diversity of cellular behavior, development, and disease (63) (64) (65) . The epigenetic heterogeneities, which are masked in conventional bulk measurements of cellular populations, are best addressed by analyzing the epigenome at the single-cell level (66) . Additionally, traditional methods are insensitive to low input samples inherent in the study of single-cell epigenetics (64) . Recent developments in microfluidic technologies make them the enabling methods for high-throughput and high-sensitivity epigenetic assays for individual cells. Using a valve-based microfluidics platform, Buenrostro et al. (67) developed a single-cell assay for transposase-accessible chromatin (scATAC-seq) (67) . They captured and lysed 96 individual cells on an integrated fluidics circuit (IFC). Then, they performed ATAC, transpose release, Tn5 end extensions, and PCR on the chip. After collecting single-cell libraries from IFC, they added cell-identifying barcodes and sequenced the pooled libraries. Using this method, they studied DNA accessibility from 254 GM12878 lymphoblastoid cells, and the data from single cells showed high similarity with bulk measurement. In addition, they evaluated chromatin accessibilities in thousands of cells from other cell lines (67) . DNA methylation, the first discovered epigenetic mark, is detected by bisulfite treatment that converts cytosine residues to uracil but spares 5-methylcytosine residues. Single-cell bisulfite sequencing and reduced-representation bisulfite sequencing were demonstrated using manual protocols with low throughput (68) (69) (70) (71) . Alternatively, a methylation-specific enzyme-discrimination method in conjunction with MDA enabled genome-scale profiling of CpG island methylation patterns in single cells (72) . These methods can be potentially integrated in microfluidic systems. For example, microfluidic diffusion-based reduced-representation bisulfite sequencing was developed to measure DNA methylomes of small numbers of cells and applied to differentiate between primary neural and primary glial cellular fractions from mouse cerebellum (73) .
Alternatively, Rotem et al. (63) demonstrated the utility of droplet microfluidics for assaying the chromatin states from thousands of individual cells. In this device, single cells were first compartmentalized with lysis buffer and micrococcal nuclease. After the cells were lysed and the chromatin was fragmented, droplets containing chromatin were merged with DNA barcoding droplets to index originating cells. Finally, the droplet contents were pooled and sequenced. Using this platform, a mixture of mouse embryonic stem (ES) cells, embryonic fibroblasts, and hematopoietic progenitors were differentiated based on their H3 lysine 4 trimethylation and dimethylation profiles. Epigenetic heterogeneities were also identified by the differences in chromatin signatures from thousands of ES cells (63) . Nanowells have also been demonstrated for a high-throughput scATAC-seq (74) . In this method, individual cells were loaded and isolated in the massively parallel nanowell array (5,184 wells). Then, the lysis buffer, transposition reagents, EDTA (ethylenediaminetetraacetic acid), MgCl 2 , and PCR reagents were added sequentially. To ensure the data were from single cells, isolated individual cells were selected and stained on the basis of the fluorescence. This method achieved high throughput (up to ∼1,800 cells per chip), short processing time (4-5 h on-chip), and low cost (<$1 per cell) (74) . By using this platform, different cell types within human peripheral blood were identified according to their epigenetic profiles (74) .
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TRANSCRIPTOME
The transcriptome, specifically at the single-cell level, offers insights into gene expression patterns that drive cellular heterogeneity. The transcriptome consists of the complete range of messenger RNA (mRNA) transcripts. The mRNA profiles of single cells change rapidly based on internal and external influences such as differentiation stages and environmental stressors, respectively. Thus, these molecules carry abundant biological information regarding cell types and states (75) .
To gain a more comprehensive picture of diverse cell states and subsets as well as circuits within cellular populations and tissues, it is crucial to look at the transcriptome (26, 76, 77) . The challenge with identifying and quantifying the transcriptome at the single-cell level is the low abundance of RNA (up to picograms) (78) . Additionally, insufficient reverse transcription and amplification efficiency lead to the dropout of transcripts with low abundance, which biases downstream analysis (26, 78) . Moreover, the volatility and degradation of RNA molecules further decrease the number of transcripts, increasing the noise and jeopardizing the accuracy and reproducibility of measurements (63, (79) (80) (81) (82) . To differentiate distinct cell types or states, discover rare subpopulations, and reduce the impact of the technical and intrinsic noise, high-throughput profiling of individual cells is necessary. However, this adds further challenges in terms of precise and fast sample manipulation and isolation (78) . Microchip-based tools are playing an important role in overcoming these limitations by enabling low-input RNA contents and processing in nanoliter reaction chambers that result in reduced contamination, reduced reagent consumption, and improved capture efficiencies (80) . The miniaturization and parallelization in microfluidic platforms also provide simpler and more scalable approaches to single-cell manipulation, allowing a highthroughput and affordable analysis of the transcriptome across a large number of individual cells (80, 83) .
Common techniques for transcriptome analysis include RNA fluorescence in situ hybridization (RNA-FISH), quantitative PCR (qPCR), and mRNA sequencing (84) (85) (86) . FISH is an effective method to detect and locate mRNAs in individual cells. Using sequential FISH and superresolution imaging, it can detect tens to thousands of mRNAs in single cells (87) (88) (89) . Matsunaga et al. (86) developed a microfluidic device to facilitate the workflow of FISH up to 100 single cells. Using polyethylene terephthalate micromesh with optimized cavity size, cell trapping was demonstrated with high efficiency in a short period of time. This device successfully differentiated variations in mRNA expression levels across different cellular populations and measured expression levels of β-actin using FISH on a single integrated device. Kao et al. (90) developed another integrated FISH microfluidic platform that detected HER2 in cancer cell lines with an entirely automated FISH procedure (Figure 3a) . By integrating multiple functions in the same device using micropumps and microvalves, the DNA probe usage and hands-on time were reduced. The reagent consumption was also reduced by 70% (90) .
Alternatively, reverse transcription qPCR is widely used in molecular biology laboratories to quantify differences in gene expression levels. This technique provides high sensitivity, high specificity, and a large dynamic range (91) and has been demonstrated for single-cell gene expression analysis, but it is unreliable with the conventional systems. Using a droplet-based microfluidic device, Eastburn et al. (92) reported 50,000 single-cell reverse transcription PCR (RT-PCR) reactions per run (Figure 3e ). Targeted cells can be identified from a mixed cell population with high specificity using this method, indicating a potential usage in rare cell analysis (92) . The droplet microfluidic platform also showed high-throughput capabilities for target cell sorting. The drawbacks of both FISH and RT-PCR platforms are that they are relative quantification methods that can detect only a finite number of known genes in each experiment (76, 79) . Thus, these methodologies are not able to uncover global information from a cell (76, 79) . These approaches also rely on a priori knowledge of target transcripts in the cells of interest, impeding the discovery of novel genes (63) .
To overcome the limitations of FISH and RT-PCR platforms, single-cell RNA sequencing is becoming the mainstay tool for profiling gene expression heterogeneity. This widely implemented methodology enables gene expression measurement at a whole-transcriptome scale in an objective and unbiased way (81) . Following the isolation and lysis of single cells, the mRNA is reverse transcribed into complementary DNA (cDNA) and amplified via whole-transcriptome amplification (WTA) prior to downstream sequencing. Two common methods for cDNA generation are oligod(T) anchoring and template switching (84, 93) . However, oligo-d(T) anchoring results in a severe 3 mRNA bias owing to its preferential amplification of the 3 ends (84). The template-switching method circumvents this issue owing to its implementation of Moloney murine leukemia virus reverse transcriptase (MMLV RT), which has terminal transferase activity and template-switching capabilities. Thus, nontemplated cytosine residues can be added to the 3 end of the cDNA by the terminal transferase activity. This results in a polyguanosine template and adaptor sequence, which allows the MMLV RT to generate full-length cDNA transcripts containing the complete 5 end of the mRNA (93) . Both methods use PCR for amplification (84, 93) . Unique molecular identifiers (UMIs) are typically used to label the original mRNA prior to WTA, which reduces amplification bias by allowing downstream normalization and quality control of the raw data (94) . The amplified cDNA libraries are then barcoded, pooled, and multiplex sequenced using next-generation sequencing (42, 95) .
As mentioned above, valve-based approaches are often low throughput and require extensive hands-on time and engineering expertise. Despite these drawbacks, valve-based methods (78, (96) (97) (98) (99) are widely used owing to their high controllability. Streets et al. (78) designed an RNA sequencing microfluidic device able to capture, lyse, and reverse-transcribe single cells on the chip, as well as perform polyA tailing, primer digestion, and second-strand cDNA synthesis (Figure 3b) . While amplification, purification, library preparation, and sequencing were conducted off-chip, the technique produced high-quality cDNA and approximately 8,000 genes per cell from 10 single mouse embryonic cells (78) . Cellular diversity has also been revealed in mouse bone marrow-derived dendritic cells, mouse brain cells, and human brain cells via this method (97) (98) (99) . However, by increasing throughput and decreasing hands-on time, for instance, through the implementation of a control software, the benefits of valve-based devices could be maximized (83, 100) . Recently, White & Streets (100) developed an open-source and low-cost circuit that can control up to 70 solenoid valves. This research suggests potential for automating previously manual valve-based microfluidics to scale the process and increase throughput. The KATARA (Kit for Arduino-based Transistor Array Actuation) also includes a python package with a graphical user interface, thereby eliminating the expertise required in operation (100).
Alternatively, microwell-based methods offer more scalability and simplicity in operation by reducing the need for specialized setups, decreasing the quantities of unused volume, and facilitating parallelization (Figure 3c) (80, 83, (101) (102) (103) Because each well can hold only a single bead, loading efficiency up to 95% has been reported. The wells were sealed with a semipermeable polycarbonate membrane as opposed to oil (102) . This membrane allowed for solution exchange during cell lysis while still trapping biological macromolecules, ensuring better mRNA capture and minimizing cross contamination. After lysis and mRNA capture, reverse transcription, amplification, library preparation, and paired-end sequencing were conducted off-chip. This device has been successfully used to investigate thousands of primary human macrophages following exposure to Mycobacterium tuberculosis (101) . Droplet-based approaches offer scalability and an inherently massively parallel platform for single-cell RNA sequencing. The most predominant approaches are the Drop-seq and InDrop platforms, which use microfluidic devices to encapsulate single cells, reagents, and either barcoded beads or hydrogel microspheres carrying barcoded primers in oil droplets (Figure 3d) (76, 77) . The barcodes consist of a PCR primer, a unique cellular barcode, a UMI to differentiate between captured mRNAs, and a poly(T) tail that acts as the binding site for the polyadenylated mRNA. The lysis, RT, and PCR steps are all performed in the droplets. Because these reactions are confined and the final amplified transcripts contain unique barcodes, these platforms allow the droplet contents to be pooled, facilitating the downstream processing for sequencing library preparation following droplet emulsification. A digital gene expression matrix can be assembled after aligning to a reference genome, bracketing cells by barcode, and determining transcript quantities based on the UMIs. A large number of mouse ES cells and retinal cells have been studied using these approaches, and detailed population structure and novel candidate cell subtypes have been revealed (76, 77) . Although these devices allow for the low-cost processing of tens of thousands of cells per hour (77), they provide minimal control during droplet formation, which leads to inefficient encapsulation. Further, mRNA capture efficiency is low, thereby limiting the reliable detection of transcripts with a lower expression level (102) . These are especially obstructive when processing small samples with a minimal amount of cells (76, 77) . Moreover, peripheral equipment is required, impeding adoption across different labs (102) .
Small RNAs, including microRNAs (miRNAs), could play a critical role in creating or modulating heterogeneous cell states (104) (105) (106) . MiRNAs are small noncoding RNA transcripts that are important regulators of gene expression in numerous biological systems. In the cell, miRNAs can regulate the expression of mRNAs through molecular complementarity, which leads to either mRNA degradation or repression of translation (107) . This allows for a more immediate response in gene expression regulation by debilitating and depleting mRNA reserves that have already been transcribed prior to halting gene transcription. ARjats.cls March 7, 2019 12:19 sequences. This recycling initiates a cyclic cascade reaction that amplifies the fluorescence without the implementation of PCR. By using this method, 300-500 cells can be processed per minute (110) . Following an analysis of three different breast cancer cells, correlations between miRNA expression levels and malignancy stage were identified (110) . Recently, new methods have been reported for capture, amplification, and sequencing of all miRNAs from low-input samples or single cells (111, 112) . Further implementation in microfluidics could lead to genome-wide profiling of miRNAs in thousands of single cells.
PROTEOME
The proteome, in addition to the transcriptome, aids in bridging the gap between genotype and phenotype. The proteome includes membrane-bound, cytosolic, and secreted proteins. Protein concentration, posttranslational modifications, organelle translocations, enzymatic or functional activity, and interactions with other proteins or molecules also influence the proteomic profile (113). Proteins act as major biological players in executing a repertoire of important cellular functions, including cellular differentiation, DNA replication, signal transduction, metabolic reactions, and molecule transportation (114) . Therefore, study of the proteome can infer biological mechanisms and enable the discovery of biomarkers, therapeutic targets, and other proteins or protein complexes relating to normal development or diseases (114) . Although proteins may have less stochastic noise compared with transcripts, it is more challenging to quantify the proteome from individual cells in high fidelity, owing in part to the size of the whole proteome, which is orders of magnitude larger than transcriptome, and the low abundance and instability of most signaling proteins (20, 75, 115) . In contrast to DNA and RNA, proteins cannot be amplified directly to improve the signal-to-noise ratio (20, 26) . The enormous complexity of the proteome and a lack of consistent and universal probes add additional difficulties for single-cell proteomic analysis (75, 116) . Current techniques are still limited in throughput and sensitivity and can measure a definite number of proteins in single cells (117) (118) (119) (120) (121) . To enable a highly sensitive and multiplexed single-cell protein assay, microfluidic platforms have been widely studied and implemented (122) . Single cells can be entrapped in nanoliter wells in which secreted proteins are captured by a glass slide precoated with antibodies for codetection of up to four proteins per cell (123) (124) (125) . Single-cell barcoding microchips enable highly multiplexed measurement of proteins at the level of single cells (126) (127) (128) (129) (130) (131) (132) (133) (134) (135) (136) (137) . Uniquely, these chips have prepatterned bands of antibodies that capture specific proteins, quantifiable in a fluorescent immunoassay. Optimizing and simplifying the operation parameters of the original SCBC, Lu et al. (130) reported a microchip design with more than 5,000 microtroughs that isolates individual cells for multiplex protein detection (Figure 4a) . Compared with valve-based methods, this workflow and device had reduced complicity and bulkiness. Cells were directly pipetted on the chip and loaded into the microtroughs via gravity. Proteins were detected by superimposing a highdensity antibody barcode array slide on top of the microtroughs, thereby creating a fluorescent immunosandwich. Following incubation for ∼12 h, the sandwich was separated, and the captured cytokines were detected using detection antibodies and visualized using a microarray scanner (130) . By combining spectral encoding with different fluorescent colors and spatial encoding with 15 stripes, the platform achieved simultaneous measurement of 42 effector proteins (130) , representing the highest multiplexing to date for a single-cell protein secretion assay. The device's compatibility with live cell culture and microscope imaging also enabled the correlative study between protein secretion profiles and cellular migration or interaction (129, (138) (139) (140) (141) . To date, this platform has been applied to the study of functional heterogeneity in cell signaling, immune responses, tumorigenesis, and cellular therapies (126, 129, 130, 135, (142) (143) (144) . Han et al. (145) demonstrated a serial microengraving approach to monitor the temporal dynamics of cytokine secretion from individual cells. In this method, single cells were distributed and isolated in a dense array of subnanoliter wells (84,672 wells) with an antibody-coated glass slide on top to monitor the release of three different cytokines. In order to measure single-cell protein secretion over different time intervals, used antibody-coated glass slides were exchanged for fresh slides at various time points (145) . Using this approach, researchers examined dynamic cytokine secretion from both nonadherent T cells and adherent macrophage cells (145, 146) . Lu et al. (130) demonstrated that an additional perturbation step could be inserted between slide exchanges. A panel of 42 secreted proteins was thus measured on the same single macrophages before and after stimulation with lipopolysaccharide (LPS), a Toll-like receptor 4 ligand.
In addition to the use of antibody-coated substrates, such as glass slides, to capture target proteins, antibodies conjugated with microbeads are a vital tool for protein measurement following single-cell isolation within droplets or microwells (Figure 4b) (147-151) . Konry et al. (147, 152) implemented droplet microfluidics to encapsulate T cells, capture-antibody-modified microspheres, and fluorescently labeled secondary antibodies to measure protein secretions. Although this method allows for the positive detection of IL-10 cytokine secretion in activated T helper cells, the assay is limited in how many parameters can be simultaneously measured and requires prolonged hands-on time. Alternatively, single cells and antibody-functionalized microbeads can also be coentrapped in microfluidic chambers or wells together with fluorescently labeled secondary antibodies. The dynamics of cellular secretory activity can then be monitored over time according to the fluorescence intensity of the microbeads (150, 151, 153) .
In addition to the conventional methodologies using valves, microwells, or droplets, nanoporeleveraging technologies have recently emerged as a new solution to read the secretome from single (Figure 4c ). This provides unique advantages, such as real-time detection, single-molecule sensitivity, and independence of a priori knowledge of antibodies (154) . To detect the secretions, a single cell was trapped with optical tweezers over a nanopore within a microfluidic device. The passage of secreted cellular proteins through the nanopore generated distinctive blockade currents, which were related to protein volume. Using this method, Kennedy et al. (154) differentiated three different cancer cell lines (U937, MDA-MB-231, and MCF-7) in real time and identified and dynamically tracked chemokine CCL5 and other low-mass biomarkers (PI3, TIMP1, and MMP1). The aforementioned approaches are used to detect cellular secretions in a nondestructive manner. However, to study intracellular proteins, it is necessary to integrate cell lysis, protein release, and subsequent detection in a microfluidic chip. One valve-based approach used single-molecule fluorescent counting to separate and quantify proteins following single-cell isolation, lysing, and labeling via a three-state valve (155) . Through this targeted approach, undesired proteins were discarded by electrophoresis, and cylindrical optics was used to quantify the proteins of interest (75, 155) . Shi et al. (134) reported a modified SCBC by introducing extra neighboring chambers containing lysis buffer (Figure 4d) . Here, trapped single cells were lysed on-chip following the diffusion of lysis buffer, and the released proteins were assayed using 11 antibody barcode stripes. Through this platform, they studied intracellular signaling proteins from three cancer glioblastoma multiforme cell lines under different stimulation conditions. To improve the sensitivity in detecting intracellular proteins with low copy numbers, microwells (60 pL) were used to increase the released protein concentration and reduce the protein diffusion time after cell lysis (136) . Using a combination of antibody-conjugated beads of 4 different sizes and 3 different fluorescent colors, Yang et al. (136) 
measured 12 proteins in the isolated circulating tumor cells (CTCs).
Alternatively, the Abseq method (156) offers a higher throughput, up to 10,000 cells per hour, and allows for examination of a greater amount of membrane proteins (Figure 4e) . This technique stains cells with DNA-tagged antibodies containing a UMI and an antibody-specific sequence, which aids in the identification of PCR duplicates and the protein of interest, respectively. After single-cell isolation, the cells are lysed using a proteinase K lysis agent. Then, via a triple-droplet merger junction, the single-cell lysate, single-cell barcode, and generated PCR droplet are merged into one. The cell-specific barcodes are then coupled with the antibody barcodes using strand overlap extension PCR (26, 156) . Assay sensitivity can be further optimized by increasing the number of DNA tags per antibody. So far, it is limited to surface proteins. However, theoretically, the sequence tags can uniquely label antibodies against intracellular, secreted proteins or the entire proteome, providing a greater opportunity for novel discoveries (156) .
Single-cell western blotting (scWestern) is another protein analysis approach. Hughes et al. (157) used scWestern to analyze thousands of single cells for 2-3 proteins per cell in a single run, but repeated bleaching and restaining could detect up to 11 protein targets (Figure 4f ). After being locked in an open microwell array, individual cells were lysed on-chip. Proteins in cell lysate were then separated using polyacrylamide gel electrophoresis and immobilized via photoinitiated blotting. Fluorescently labeled antibody probing was conducted and visualized with a microarray scanner (158) . This method enabled Hughes et al. to not only detect proteins but also distinguish isoforms. It was applied to the analysis of rat neural stem cells, glioblastoma cells, CTCs, and different subcellular compartments (157, 159, 160) .
Finally, cell immunostaining is a straightforward technique for intracellular protein detection and can be readily integrated in microfluidic chips. Single cells can be isolated using a hydrodynamic trapping array, electroactive microwell array, or digital microfluidic device and stained by immunocytochemical reagents (161) (162) (163) (164) 
METABOLOME
Metabolites provide yet another bridge between genotype and phenotype on the single-cell level. The metabolome encompasses all of the intracellular, cell membrane-bound, and secreted metabolites, including lipids and carbohydrates (166) . Single-cell metabolite profiles, when integrated with other omics data, are helpful in identifying genotype-phenotype correlations by providing a more comprehensive picture of metabolism intermediates (81, 167) . More recently, metabolomics has had applications in drug development and delivery, toxicology, and biomarker discovery (167) (168) (169) (170) . However, because metabolites are smaller than biomolecules like DNA and protein, they are even more difficult to characterize (166) . Traditionally, multiple singlecell-isolation platforms, such as laser ablation electrospray ionization and matrix-assisted laser desorption/ionization, have been coupled with mass spectrometry to investigate the metabolome (171) (172) (173) . Still, conventional methods cannot deal with such a small sample size without disproportionate sample dilution or overall sample loss (174) . These methods also lack the sensitivity required to detect low-quantity metabolites present in a single cell (174) . Microfluidic devices offer great potential as powerful tools for higher-throughput metabolomic studies on single cells. Although microfluidic devices have been used as a culturing platform to investigate metabolites, few studies have applied these devices to investigate the metabolome at the single-cell level (175) (176) (177) . Another challenge remains in that most single-cell devices have arisen only for specific metabolites, restricting their application to niche specialties and failing to achieve highly multiplexed metabolite analysis. Further, because the specific metabolites are based on a priori knowledge, the opportunity for novel discoveries is limited with microdevice technologies. Whereas microfluidics holds great promise in increasing throughput, they pose challenges in altering normal cell behavior (174) . This can lead to artifacts that can be detrimental to metabolome studies owing to their inherently minuscule concentration at the single-cell level. In spite of these challenges, progress toward a single-cell metabolomics system is still under way.
Cheng et al. (178) presented a microelectrode-microfluidic system that generated a metabolic profile of single beating heart cells. Following microelectrode field stimulation, which artificially mimicked a beating heart, an electrochemical biosensor measured the cells' lactate production. Extracellular pH and cellular calcium fluorescence, as well as cell contractility, were also assessed via in situ microscopy, thereby shedding light on the electrical and metabolic state of the heart cell.
In a higher-throughput study, Boedicker et al. (179) used plug-based microfluidics to trap single bacterial cells into nanoliter droplets. Released metabolites can be more easily detected through stochastic confinement in which the metabolites remain in close proximity to the cell. By using the metabolite profiles of methicillin-resistant S. aureus, the minimal inhibitory concentration of the drug was determined, and sensitive and resistant strains of S. aureus were identified from human blood plasma samples. This platform facilitated multiple measurements on the same sample, illustrating its applications in efficient point-of-care diagnostics and patient-specific treatment of bacterial infections.
Single-cell metabolites can be detected in microwells using specific sensing molecules (180) (181) (182) . Tang et al. (182) developed a microwell chip platform for glucose uptake measurement in tumor cells from pleural effusion (Figure 5a ). After cells were loaded onto the device with 200,000 microwells and incubated with a fluorescent glucose analog, 2-NBDG, the microwell chip was scanned by an automated high-speed fluorescence microscope. Images were analyzed with a computational algorithm to identify cancer cells exhibiting high glucose uptake for subsequent single-cell sequencing. Moreover, Molter et al. (180) designed a glass microwell chip that contained an oxygen sensor made of platinum phosphor-polystyrene beads attached along the base of the well. Following submersion in growth media and cell seeding, the chamber was closed with a glass lid attached to a piston to create an airtight seal over the microwells and measure oxygen consumption. Alternatively, Xue et al. (183) reported an integrated and automated microchip-based multiplexed assay of metabolites and proteins from single cells via an SCBC (Figure 5b) . Using the DEAL method, they immobilized metabolite-specific supramolecular probes and protein-capturing antibodies in a barcode attached to the single-cell microchamber. Single cells (∼100 cells per chip) were lysed on-chip via a reservoir of lysis buffer, divided by a programmable valve. Metabolites were detected via a competitive binding assay, whereas proteins were visualized using a sandwich immunofluorescence assay. Using this platform, the researchers investigated the metabolome of single patient-derived glioblastoma neurosphere tumor model cells after 24 h of treatment with erlotinib, an epidermal growth factor receptor inhibitor (EGFR) that reduces glucose consumption in tumor cells. As a proxy for glucose consumption, four metabolites and seven metabolism-related proteins and phosphoproteins were included in the panel, revealing an overall reduction in glucose intake. Furthermore, from the incorporation of multiple metabolites, two distinct metabolic phenotypes could be identified (183) . In addition, Xue et al. (184) developed an SCBC chip that also incorporated a surface competition assay for quantifying glutamine uptake from single cells. They analyzed 16 metabolites, phosphoproteins, and relevant metabolism enzymes. Building on previous work, they used the chip to study correlations between energy potential with receptor tyrosine kinase signaling following erlotinib treatment. These single-cell studies revealed that cellular energy potential increased in cancer cells despite the reduction in glucose uptake and phosphoprotein signaling. Moreover, they identified novel interactions between cellular energy processes and phosphoprotein signaling that could explain resistance to EGFR inhibitors demonstrated in cancer patient cohorts (184).
MULTI-OMICS
Despite advances in genomic, epigenomic, transcriptomic, proteomic, and metabolomic technologies for analyzing single cells, assessment of each type of molecule separately is inadequate to fully understand complicated biological systems and their underlying regulatory mechanisms (137) . By measuring multiple omic levels of the same single cells, as opposed to merging various data sets obtained from different cells, genotype-phenotype connections can be determined unambiguously. Additionally, the integration of information from multi-omics can provide unique clues that are not readily available from mono-omic assays (183) . Through these paralleled studies, more complex mechanisms of actions underlying cellular heterogeneity can be elucidated. For example, the integrated study of epigenomes and transcriptomes leads to a greater understanding of the regulation of cellular identities, functions, and phenotypes that are not solely predicted by genotype (185) . Additionally, cosequencing miRNA and mRNA presents new opportunities to study posttranscriptional regulation of nongenetic cellular heterogeneity by miRNAs and modulation of miRNA variability via protein-coding genes (186) . Moreover, single-cell transcriptome and proteome studies offer insights into expression dynamics. As these studies provide a more comprehensive representation of cellular heterogeneity, the applications in human health and disease will continue to advance (187) . With such a vast potential for enhancing understanding and progressing medicine, microfluidic devices are now starting to be used to drive multi-omic studies further (75) . However, it is still challenging to profile multiple omic layers on the same cell in a single device. This is due to the incompatibility of various biomolecule assays and protocols with distinct sensitivity and specificity requirements (26, 183) .
Han et al. (188) reported an integrated microchip platform with controllable membrane valves for simultaneous WGA and WTA of the same single cell, permitting comeasurement of genes and transcripts from identical individual cells. This approach allowed for the on-chip isolation and amplification of cytoplasmic mRNA and nuclear gDNA from the same single cell. After single cells were captured in the microchamber, the cell membrane and nucleus were lysed consecutively using highly selective lysis buffers, and the cytoplasmic and nuclear contents were collected separately. Then, mRNA was reverse transcribed to cDNA on the device, and whole-pool amplification of both cDNA and gDNA from the same single cell was performed (188 cell were identified (188) . This advancement offers the ability to investigate stem cell fate control, nongenetic cell-to-cell variability, epigenetic regulation, and other fundamental biology questions (188, 189) . Strijp et al. (190) developed another method to investigate the genome and transcriptome using pressure-driven microfluidics. On a microfluidic chip, individual cells were captured by hydrodynamic traps followed by on-chip DNA and RNA extraction via the sequential introduction of the cell membrane and nucleus lysis buffer. This two-stage lysis protocol avoided the need for additional washing steps, thereby reducing sample loss. The lysates were collected from individual trap outlets following on-chip WGA for DNA. After off-chip reverse transcription and amplification for RNA, the sample was profiled by sequencing. This technique and Bayesian computational pathway modeling were used to identify tumor-driving pathways in individual cells from colorectal cancer cell lines based off of the transcript data. The driver mutations behind these pathways were derived from the DNA of the same single cells. This platform shows promise in the investigation of cellular heterogeneity within tumors and in analyzing single CTCs through its establishment of functional and mutational pathways (190) . To simultaneously interrogate DNA methylation and gene expression in single cells, Cheow et al. (191) implemented a valve-based, automated, high-throughput microfluidic platform, termed single-cell analysis of genotype, expression, and methylation, to investigate primary lung adenocarcinomas and human fibroblasts undergoing reprogramming.
The interaction between transcripts and proteins is another topic in single-cell multi-omics studies. George & Wang (192) developed a microfluidic device to enable the same single-cell study of transcripts and secreted proteins. This splittable single-cell microchip integrated a high-density antibody array to detect protein secretion from isolated single cells in collagen-coated nanowells. After proteins were profiled via an ELISA (enzyme-linked immunosorbent assay), single cells were manually selected for mRNA sequencing by WTA. Using this workflow, they identified a subset of highly coexpressed genes that correlated with tumor necrosis factor α secretion in mouse macrophage cells, illustrating its potential to provide novel understandings of the immune system's regulatory mechanisms (192) . Using a valve-based automated microfluidic platform, Junkin et al. (153) measured cytokine dynamics and the mRNA transcripts of LPS-stimulated macrophages on the same device. Antibody-functionalized beads were cocultured with single cells to measure the cytokine secretions. The cytokines were quantified by bead fluorescence intensity using sandwich immunoassays. Single cells at the endpoint were then subjected to mRNA detection (153) . A valve-based platform has also been used to assess the response of the transcriptome and proteome in MCF7 cells under phorbol-12-myristate-13-acetate perturbation (193) .
Droplet microfluidic devices are another powerful tool to simultaneously measure RNA expression and protein (194) (195) (196) . Following cell incubation with DNA-barcoded antibodies, the stained cells were encapsulated in nanoliter droplet with beads, which can capture mRNAs and antibody-tagged oligos. After reverse transcription, amplification, and sequencing, the information from the transcriptome and proteome can be deconvoluted. This method was used to study the heterogeneity of human CD8 + lymphocytes and cord blood mononuclear cell proteins (194, 195) . More recently, an aptamer-based technique has also been designed to study the transcriptome and proteome in parallel (196) . By using aptamer probes, cells expressing epitopes and surface proteins of interest were labeled and coencapsulated with DNA barcode beads and the lysis solution. The polyA sequence of mRNAs and aptamers allowed for their hybridization with the beads following cell lysis. After RT and DNA polymerase reactions, the droplet contents were pooled and sequenced in parallel. The epitome and transcriptome data could be analyzed in tandem owing to the shared cell-specific barcode. This platform allowed for the differentiation of distinct cell types based on aptamer surface binding and gene expression patterns (196 As described above, Xue et al. (183, 184) reported a valve-based SCBC that integrated surfacecompetitive binding assays with functional protein immunoassays and fluorescence readouts to study the metabolites and proteins simultaneously. Additionally, Zhang et al. (137) used nanowells to demonstrate a microchip-based platform capable of detecting glucose uptake and intracellular functional proteins from individual CTCs using image-based cytometry and antibody barcode microarrays. The individual nuclei from lysed cells were retrieved to subsequently study genetic mutations.
CONCLUSIONS AND FUTURE DIRECTIONS
Miniaturization and parallelization in microchip-based technologies offer unprecedented opportunities for the study of single-cell omics owing to improved throughput, sensitivity, and controllability and reduced sample consumption. As discussed in this review, the novel and unique discoveries of cellular development and heterogeneity from these methodologies are now providing new frontiers in both fundamental research and precision medicine.
Despite previous endeavors, there are still enormous unsolved problems in single-cell omics measurement using microfluidic platforms. One area of future research will be to further improve sensitivity, throughput, and multiplexity to reduce errors and bias in omics measurement. Moreover, the variety of microchip devices with different modalities imposes a great challenge in quality control; thus, establishing standards for performance assessment and result interpretation will be crucial for future developments.
In addition, measuring multiple levels of omic properties from the same cell in parallel is still imperfect but necessary to achieve a more accurate and comprehensive picture of cellular types and states. Despite recent progress in integrative multi-omics, most of these technologies can assess only two or three omic layers simultaneously. The ideal platform will provide more benefits from the integration of information from all molecular levels. Additionally, linking these integrative characteristics of cellular omics with cellular phenotype (e.g., cell size and morphology) and dynamics (e.g., cell growth, proliferation, migration, and cell-cell interactions) in the microchip platform has great potential for a more information-rich output. To obtain the links from the same single cell, a precise and facile retrieval method for downstream molecule profiling is required. It will be exciting to fully grasp how molecular properties translate into cellular behavior at the single-cell level. These projected advances will likely increase the complexity and breadth of single-cell data sets, creating the need for innovative computational models to decipher the high dimensionality of the data. Furthermore, means for interrogating multi-omics data while retaining spatial information from 3D positional anatomy during single-cell processing are still underdeveloped, impeding complete understanding of structure and function in complex biological tissues.
Finally, the commercialization and clinical translation of microchip-based technologies are still challenging and slow. To accelerate the widespread use of these technologies in biology and medicine, robust and user-friendly device designs must be developed. The integration and automation of the microfluidic devices will not only lower the adoption barrier for biologists and clinicians but also reduce human intervention and time commitment. This will limit user bias and improve repeatability across different labs, which are notable issues in current manual protocols. Cost is likely to be another barrier for the widespread implementation of microchips in single-cell omics measurements, which may be solved by further improving workflows that scale down volumes of reaction reagents and increase sample processing capacity. The standardized and scaled production of these devices will also help reduce costs.
Through the streamlined integration of genomics, epigenomics, transcriptomics, proteomics, and metabolomics using multi-omics microfluidic approaches, the full extent of cellular heterogeneity can be realized. By tackling these challenges of throughput, low sensitivity, low number of omic layers, lack of adequate and feasible computational models, and high cost of microfluidic devices, researchers and practitioners can implement these technologies in the discovery of cellular subtypes and substrates as they relate to health and disease, thereby propelling widespread use of single-cell omics in life science and medicine.
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